MANALAPAN, N.J., Aug. 2, 2018 /PRNewswire-PRWeb/ -- RxS LLC ("RxS"), a privately held company providing multi-channel
Jara was recently reelected to a three-year term on the Prescription Drug Marketing Act (PDMA) Alliance board, where his technical background provides a unique perspective in introducing technology to the forefront of compliance solutions. Jara will be a featured presenter at the PDMA's 2018 Sharing Conference in October.
Partly through experience, partly through careful listening to prospective and existing clients, Jara has a keen understanding of RxS client needs when it comes to sample management. Some have commented that through Jara's leadership, RxS goes beyond simply being a "preferred vendor" by uncovering opportunities to bring significant value to the partnership.
A service organization enabled by technology, RxS is the leading provider of multi-channel sample management solutions for pharmaceutical and biotech companies. The RxS leadership team has logged decades of experience and key learnings with state-of-the-art technology to deliver unparalleled regulatory compliance services. Offering a suite of proprietary services, RxS removes the administrative burden of the PDMA, ensuring compliance, maximizing data analytics and increased marketing and sample effectiveness.
When people meet Jara, it is quickly apparent that he possesses a positive, energetic, and enthusiastic "can-do" attitude, along with a willingness to take whatever steps are required to complete the job. Through these attributes, some believe Jara is helping reshape the industry and changing the way other vendors in the sample management space go about their jobs.
"All of us at RxS are tremendously happy for Mark in receiving this well-deserved distinction," notes Roseanne Branciforte, co-founder of RxS. "He inspires trust and respect from our team because he is true to his word and, through his leadership, RxS delivers results – often beyond client expectations. Mark has always demonstrated a tremendous work ethic and a wealth of knowledge and expertise in the sample management space that I have not seen in anyone else in the industry."
More than 10 years ago, PharmaVOICE magazine created the PharmaVOICE 100, an annual list of 100 individuals honored for their positive impact on the life sciences industry. Several thousand are nominated but only 100 individuals receive the honor. Recipients are selected based on substantive accounts that demonstrate how they have inspired or motivated their colleagues, peers, and competitors; have positively contributed to their own companies; and have given back to their communities and other philanthropic causes.
To view the complete PharmaVOICE 100 profile for Jara, please visit the July/August 2018 online digital edition at pharmavoice.com/digital-edition/july-august-2018/#107. To learn more about Jara and the RxS offerings, please visit rxsinfo.com.
About RxS LLC RxS LLC, a privately held company in Manalapan, New Jersey, is the leading provider of multi-channel sample management solutions for pharmaceutical and biotech companies. Supported by more than 75 years of combined pharmaceutical leadership experience, RxS has been partnering with pharmaceutical and biotech companies since its founding in 2011 to provide regulatory compliance in order to lessen the administrative burden of the Prescription Drug Marketing Act. RxS offerings go beyond regulatory compliance, providing solutions to increase marketing and sample effectiveness. Driven by technology, RxS offers a suite of proprietary services and software solutions to ensure regulatory compliance and maximize analytics data. RxS's commitment to innovative solutions extends beyond their service offerings and into the community through a unique partnership with Academy Learning Centers where students with disabilities are offered employment opportunities to help develop self-reliance and foster an improved sense of self.
SOURCE RxS LLC
Subscribe to our Free Newsletters!